Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 39.55 EUR 0.89% Market Closed
Market Cap: 2.1B EUR

Intrinsic Value

The intrinsic value of one DMP stock under the Base Case scenario is 44.25 EUR. Compared to the current market price of 39.55 EUR, Dermapharm Holding SE is Undervalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DMP Intrinsic Value
44.25 EUR
Undervaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dermapharm Holding SE

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
DMP
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for DMP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Dermapharm Holding SE
XETRA:DMP
DE
Pharmaceuticals
Market Cap
2.1B EUR
IPO
Feb 9, 2018
DE
Pharmaceuticals
Market Cap
2.1B EUR
IPO
Feb 9, 2018
Price
false
EPS
false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Dermapharm Holding SE
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dermapharm Holding SE

Current Assets 593.5m
Cash & Short-Term Investments 124.8m
Receivables 102.1m
Other Current Assets 366.7m
Non-Current Assets 1.5B
Long-Term Investments 82.8m
PP&E 315m
Intangibles 1.1B
Other Non-Current Assets -1k
Efficiency

Free Cash Flow Analysis
Dermapharm Holding SE

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dermapharm Holding SE

Revenue
1.2B EUR
Cost of Revenue
-413.7m EUR
Gross Profit
767.1m EUR
Operating Expenses
-539.3m EUR
Operating Income
227.8m EUR
Other Expenses
-114m EUR
Net Income
113.8m EUR
Fundamental Scores

DMP Profitability Score
Profitability Due Diligence

Dermapharm Holding SE's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Operating Income
60/100
Profitability
Score

Dermapharm Holding SE's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

DMP Solvency Score
Solvency Due Diligence

Dermapharm Holding SE's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Average Altman Z-Score
38/100
Solvency
Score

Dermapharm Holding SE's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DMP Price Targets Summary
Dermapharm Holding SE

Wall Street analysts forecast DMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMP is 47.43 EUR with a low forecast of 44.44 EUR and a high forecast of 51.45 EUR.

Lowest
Price Target
44.44 EUR
12% Upside
Average
Price Target
47.43 EUR
20% Upside
Highest
Price Target
51.45 EUR
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
May 11, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for DMP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DMP Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DMP stock?

The intrinsic value of one DMP stock under the Base Case scenario is 44.25 EUR.

Is DMP stock undervalued or overvalued?

Compared to the current market price of 39.55 EUR, Dermapharm Holding SE is Undervalued by 11%.

Back to Top